Glass House (GLAS) Q3 2026 Earnings Call Transcript
Glass House (GLAS) reported Q3 2026 revenue of $56.8M, up from $26.2M YoY, driven by record biomass production of 319,000 pounds. However, gross margin declined to 26% due to pricing pressure and a trim-heavy sales mix. The company maintained its annual biomass production guidance of 1M pounds and plans $20M in capital expenditures. Cash reserves stand at $39.7M, with management expecting positive cash flow.
How this was made

The 30-second read
Why it matters
Key trading inputs are the sharp ASP decline, trim-heavy sales mix, gross margin deterioration, and negative operating cash flow, alongside stable Q4 cost guidance and reaffirmed full-year biomass production target. These jointly shape expectations for Q4 profitability and cash generation.
Market read
Traders can update near-term margin and cash-flow expectations using the call’s quantified mix, ASP, gross margin, and guidance for Q4 costs.
What to watch
The company’s NYSE uplisting and professional-fee drag, plus the timing lag between harvest and sale, may make current-quarter margin weakness less predictive of subsequent periods once mix improvements flow through.
Background
The article is a transcript of Glass House Brands’ Q3 2026 earnings call, covering financial results, operational metrics, guidance, and management updates (including CFO retirement and auditor reappointment).
Ticker impact
Glass House Brands reported Q3 revenue of $56.8M, record 319,000 lbs production, and guided Q4 cost at $109/lb amid trim-heavy mix and pricing compression.
Likely near-term pressure as investors focus on lower gross margin (26% vs 34% in Q2) and negative operating cash flow, despite stable Q4 cost guidance and full-year biomass target.
The call provides specific, decision-relevant datapoints: lower ASP ($151 vs $211 prior quarter), gross margin decline, negative operating cash flow, and explicit Q4 cost guidance ($109/lb) plus full-year biomass guidance (1M lbs).
Market effects
Highlights ongoing cannabis cultivation economics challenges: product-mix sensitivity (trim vs flower/smalls) and regional wholesale price compression.
Emphasizes California wholesale price compression as a key driver of ASP weakness, which can influence regional peers’ margin expectations.
International medical market certification progress (GACP) supports longer-dated optionality, but near-term results remain driven by US pricing and mix.
Counterpoint
Record production and a lower cost per pound (down 10.7% vs Q2) could allow margins to stabilize if management’s greenhouse optimization improves flower and smalls mix with a lag into future quarters.
Key entities
- companyGlass House Brands
Reported Q3 2026 results and provided Q4 cost guidance and full-year biomass production guidance.
- executiveKyle Kazan
CEO commentary on trim mix impact and compressed California wholesale pricing.
- executiveMark Vendetti
CFO commentary on pricing softness and retirement effective end of March 2027.
- executiveGraham Farrar
President commentary on cogen power impacts on yields and mix improvements lag.